MVP and KCTD9

  • Number of citations of the paper that reports this interaction (PMID 24722188)
  • 1
  • Data Source:
  • BioGRID (two hybrid)

MVP

KCTD9

Gene Name major vault protein potassium channel tetramerization domain containing 9
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 57 interactors: ADAMTSL4 AES BANP BZRAP1 C1orf94 CALCOCO2 CAMK2B CCDC36 CKAP4 CYTB DISC1 DLX2 EPHX2 ESR1 FAM154A FAM46C GIT2 GOLGA2 HP KCTD9 KPNA2 KPNA3 MDFI MEOX1 MEOX2 MID2 MKL1 NNT NOTCH2NL OBFC1 PARP4 PIH1D2 PLSCR1 POT1 PSTPIP1 PTEN PTPN11 RAB3IP RBPMS REL RHOXF2 RIMBP3 RNF111 SERTAD1 SKIL SLC2A4 TCF4 TFCP2 TP53 TRAF2 TRIM27 TRIM42 TRIP13 TRIP6 VAC14 ZBTB32 ZMIZ2 29 interactors: AQP1 CARD9 CBX8 CCDC33 CRADD CUL3 EHHADH FAM124B FAM208B GEM GORASP2 KRT40 LONRF1 MAD2L2 MVP NUP35 PNKD PPP1R16B PPP1R18 PSMA1 PSMB2 RBPMS SDCBP SKP1 STX11 SYT6 TRIM27 TRIM32 TRIM42
Entrez ID 9961 54793
HPRD ID 05475 13772
Ensembl ID ENSG00000013364 ENSG00000104756
Uniprot IDs B4DP93 Q14764 B4DPW0 Q7L273
PDB IDs 1Y7X
Enriched GO Terms of Interacting Partners?
Tagcloud ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
Tagcloud (Difference) ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
Tagcloud (Intersection) ?